Related Experiment Videos

Role of adherence in the pathogenesis of neonatal group B streptococcal infection

Infection and Immunity
|February 1, 1983
PubMed

Insights

Group B Streptococcus type III strains attach better to infant cells than adult cells, especially in infected infants. This suggests infants may have more attachment sites for these virulent bacteria.

Area of Science:

  • Microbiology
  • Neonatal Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Group B Streptococcus (GBS) is a leading cause of invasive infections in neonates.
  • Understanding GBS adherence to host cells is crucial for preventing neonatal disease.
  • Specific GBS serotypes exhibit varying virulence and adherence properties.

Purpose of the Study:

  • To investigate the adherence of different GBS serotypes to buccal epithelial cells from adults, healthy neonates, and infants with invasive GBS infection.
  • To determine if GBS adherence correlates with host age and infection status.
  • To identify potential mechanisms underlying enhanced GBS attachment in neonates.

Main Methods:

  • Use of (3)H-labeled GBS strains incubated with buccal epithelial cells at a 1,000:1 bacteria-to-cell ratio.
  • Comparison of adherence levels across different GBS serotypes (Ia, II, III).
  • Assessment of adherence to cells from adult volunteers, healthy neonates, and infants with invasive GBS infection.

Main Results:

  • Type III GBS adhered significantly better to healthy neonatal cells than adult cells (31 vs. 7 bacteria/cell).
  • GBS strains from infected infants showed greater adherence to infected infant cells than control infant cells (39 vs. 18 bacteria/cell).
  • No significant differences in adherence were observed for type Ia or II strains between neonates and adults.

Conclusions:

  • The most virulent GBS serotype for neonates (type III) exhibits enhanced adherence to neonatal epithelial cells.
  • Infants with invasive GBS infection may possess increased epithelial cell receptors for GBS attachment.
  • Bacterial products could potentially unmask or enhance receptor sites for GBS adherence in infants.

Related Concept Videos